Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease
Journal of the American Society of Nephrology · 2026-07 · 37 (7) · 1423-1437
DOI: 10.1681/asn.0000000980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 16.12.2025. Verfasst von Zemeng Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, Amy P. Goldman Foundation.
Abstract (Originalsprache)
Key Points Dual inactivation of Glis3 and Pkd1 exacerbated polycystic kidney disease compared with Pkd1 inactivation alone in mouse models of autosomal dominant polycystic kidney disease. RNA-Seq and ATAC-Seq suggested Glis3 inactivation resulted in dysregulated fatty acid metabolism and alteration of circadian regulation. Glis3 was involved in a transcriptional network consisting of the transcription factors HNF1 homeobox B, hepatic nuclear factor 4, alpha, and D site albumin promoter binding protein.
Background
Autosomal dominant polycystic kidney disease is caused by mutations affecting polycystin-1 or polycystin-2. The existence of a cilia-dependent cyst activation pathway has been identified by showing that structurally intact primary cilia are crucial for rapid cyst growth following loss of polycystins. We previously used translating ribosome affinity purification RNA-Seq on precystic mouse kidneys to determine a translatome that meets the criteria for cilia-dependent cyst activation. From this, we identified Glis2 as an early effector of polycystin signaling and a potential target for therapy. Here, we investigate the role of Glis3 which, while not transcriptionally altered in autosomal dominant polycystic kidney disease models, encodes a cilia-localized transcription factor belonging to the same gene family as Glis2 .
Methods
We used live cell imaging along with gene and protein expression studies to determine the relationships between Glis3, Glis2, and polycystin-1 expression. We used Glis3 conditional knockout mice to investigate the in vivo genetic interaction between Glis3 and Pkd1 . We used gene expression and chromatin accessibility analyses by RNA-Seq and ATAC-Seq, respectively, on an allelic series of Glis3 and Pkd1 inactivation models to explore the genetic relationships between the two genes.
Results
The ciliary localization of Glis3 was not affected by Pkd1 mutation status. Kidney selective inactivation of Glis3 by itself did not affect kidney structure or function, but dual inactivation of Glis3 and Pkd1 significantly worsened polycystic kidney disease. Integration of transcriptomic profiling and chromatin accessibility assays suggested that kidney tubule-specific Glis3 inactivation resulted in dysregulated fatty acid metabolism and alteration of circadian regulation.
Conclusions
Glis3 is a primary cilium localized transcription factor that genetically interacts with Pkd1 and modifies kidney epithelial cell metabolism and circadian function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
- Department of Genetics, Yale School of Medicine, New Haven, Connecticut.
- Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut.
- Computational Biology and Bioinformatics Program, Yale University, New Haven, Connecticut.
ORCID-Profile: Zemeng Wei, Jianlei Gu, Xin Tian, Chao Zhang, Hongyu Zhao, Stefan Somlo
Förderung
- NIDDK NIH HHS
- NICHD NIH HHS
- Amy P. Goldman Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Wei, Z., Gu, J., Tian, X., Zhang, C., Zhao, H., & Somlo, S. (2026). Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology, 37(7), 1423-1437. https://doi.org/10.1681/asn.0000000980
Vancouver
Wei Z, Gu J, Tian X, Zhang C, Zhao H, Somlo S. Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 2026;37(7):1423-1437. doi:10.1681/asn.0000000980
BibTeX
@article{Wei2026,
author = {Wei, Zemeng and Gu, Jianlei and Tian, Xin and Zhang, Chao and Zhao, Hongyu and Somlo, Stefan},
title = {Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {7},
pages = {1423--1437},
doi = {10.1681/asn.0000000980}
}
EUVIMED